Home › Cases › Haemoptysis and an AKI
Massive Haemoptysis
Haemoptysis and an AKI
6 questions
Question 1 · Two problems or one
Correct answer: Pulmonary-renal syndrome — a small vessel vasculitis until excluded
Why
Haemoptysis with an AKI and an active urinary sediment is a pulmonary-renal syndrome until excluded — ANCA-associated vasculitis or anti-GBM disease. Blood and protein on the dipstick in a patient who is bleeding into their lungs is not a coincidence.
This is a same-day renal and rheumatology conversation, not a next-morning one. Both diseases destroy kidneys within days, and anti-GBM disease in particular moves fast.
Sepsis and PE do not produce a nephritic urine dipstick.
Key point
Haemoptysis + AKI + blood and protein on dipstick = vasculitis until excluded. Same-day referral.
Question 2 · The investigations
Correct answer: ANCA, anti-GBM antibody, complement, ANA, plus urine protein:creatinine ratio and microscopy
Why
The immunology goes off today, because the turnaround dictates when treatment can start and the disease does not wait for it. ANCA, anti-GBM, complement, ANA, with a urine protein:creatinine ratio and microscopy for casts.
Imaging still matters — a CT chest to characterise the haemorrhage — and so does excluding infection.
What this must not become is a respiratory work-up alone. The kidney is the organ that will be lost first, and a two-week-wait referral is the wrong timescale entirely.
Key point
Send the vasculitis screen today. The kidney is lost in days, not weeks.
Question 3 · It gets worse
Correct answer: Airway, oxygen, and lie him left side down; call critical care, respiratory and IR in parallel
Why
This is now massive haemoptysis, and the massive haemoptysis management takes over: the bleeding side goes down to protect the good lung, because patients drown before they exsanguinate.
His CT localises the haemorrhage to the left upper lobe, so left side down. High-flow oxygen and suction to hand.
Critical care, respiratory and interventional radiology in parallel, not one after the other. Immunosuppression is the definitive treatment for the underlying disease and is a specialist decision — it is not the next ten minutes.
Key point
Life-threatening haemoptysis management comes first, whatever the cause. Known bleeding side, downwards.
Question 4 · Bleeding and clotting
Correct answer: That there is no correctable coagulopathy — the bleeding is from the disease
Why
Reversing anticoagulation is often the whole story in haemoptysis — and here there is nothing to reverse. That is useful information: it removes the easiest intervention and points all the weight at the underlying alveolar haemorrhage.
Still send group and save and crossmatch, and get large-bore access.
Tranexamic acid — 1g IV or 500mg nebulised — remains reasonable: modest evidence, low risk. It is not contraindicated by normal clotting.
Key point
Normal clotting removes the easy fix. Access and crossmatch still stand.
Question 5 · Definitive treatment
Correct answer: Plasma exchange with immunosuppression, under renal and respiratory care
Why
Anti-GBM disease is treated with plasma exchange plus immunosuppression, urgently — the antibody is removed while its production is suppressed, and delay costs kidneys and sometimes lives.
Embolisation treats a bleeding bronchial artery. Diffuse alveolar haemorrhage is not a single vessel, so it is not the answer here, though IR were right to be involved while the source was unknown.
This is firmly a specialist decision — the F1 contribution is recognising the pattern early enough for it to be made.
Key point
Anti-GBM means plasma exchange and immunosuppression, not embolisation.
Question 6 · What the F1 gets right
Correct answer: Reading the dipstick alongside the haemoptysis, and referring the same day
Why
Putting the two findings together. Haemoptysis and an AKI are each common and each get their own referral; read together, on the same day, they are a vasculitis.
The rest — CT, tranexamic acid, crossmatch — is good care that would have happened anyway. The pattern recognition is the part that only happens if somebody looks at the dipstick.
That is also why a urine dipstick belongs in the haemoptysis work-up, which is not where most people would think to put it.
Key point
Dipstick the urine in anyone with haemoptysis. The two findings together change the timescale.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.